The aim of this work was to study the effect of site of intramuscular administration of anaesthetic drugs on the course of immobilisation in macaque monkeys (Macaca mulatta). Twenty macaque monkeys were given medetomidine (25 µg·kg -1 ) and ketamine (3 mg·kg -1 ) intramuscularly to the deltoid (n = 10 animals) or gluteus (n = 10 animals) muscles. Behavioural changes, loss of aggressiveness, immobilisation time and cardiorespiratory changes were recorded. The effect of drugs was reversed after 20 min by i.m. administration of atipamezole at the dose of 250 µg·kg -1 . Highly significant differences (P < 0.001) were found between groups with gluteal or deltoid administration of drugs on the onset of immobilisation effect (71.3 s and 108.3 s, respectively), and immobilisation time (152.7 s and 254.4 s, respectively). In the gluteus muscle group, the grasp reflex was still present at the beginning of immobilisation and slowly wore off in 15-45 s. The same was valid for muscle tone. There were no differences in cardiorespiratory parameters in any of the groups. Animals of both groups recovered in 3-6 min after atipamezole administration. Administration of drugs to the deltoid muscle resulted in a more rapid onset and increased effect of immobilisation than administration to the gluteus muscle. Both in veterinary and human medicine, injection to the deltoid muscle may be more convenient in all cases, when rapid and more prominent effect is desirable as in premedication before surgery or in emergency medicine. The study is the first to compare the effect of administering drugs to different muscles and the results may improve the practice of intramuscular injections in animals and in humans.
Intramuscular administration of various drugs used for anaesthesia and analgesia in humans is used in anaesthetic practice as well as in pre-hospital treatment mainly in burned patients or victims of a disaster. Many drugs including ketamine, benzodiazepines, opioids, anticholinergic drugs etc. are used by intramuscular route. In humans, a gluteal muscle is the most commonly used site of injection. Time to the onset of desired effect may be as long as 30 min and the effect may vary substantially (Tuttle 1977) . Intramuscular anaesthesia and immobilisation are frequently used in veterinary medicine and the administration site is usually the deltoid muscle.
The aim of this study was to compare the differences in time of onset of sedation and immobilisation between administration of anaesthetic drugs (medetomidine and ketamine) to deltoid and gluteus muscles in rhesus monkeys.
Methods

Animals
For the purpose of this study, twenty rhesus monkeys (Macaca mulatta), weighing 2.2-3.6 kg, 1-2 years of age, 10 males and 10 females were obtained from Biotest Konarovice, Czech Republic. The monkeys were housed in individual cages with an outdoor closure. Food and water were available ad libitum. Access to food was restricted 12 h prior to the start of the experiment procedure; access to water was not restricted. The study was approved by the Expert Committee for Protection of Experimental Animals of the IKEM Institute for Clinical and Experimental Medicine and was performed in accordance with the Animal Protection Act of the Czech Republic (No. 246/1992 Sb) .
Drugs
The following drugs were provided as standard commercial solutions: medetomidine (Domitor, Orion, Farmous Group-Finland) 1 mg·ml -1 , ketamine (Narketan, Vétoquinol, France) 100 mg·ml -1 and atipamezole (Antisedan, Orion, Farmous Group-Finland) 5 mg·ml -1 .
Procedure
The weight of animals was measured before the experiment capturing the animal into a dip net. A 1 ml syringe with 23 G, 25 mm needle was used for injection. An intramuscular injection of a combination of medetomidine (25 µg·kg -1 ) and ketamine (3 mg·kg -1
) was administered either into the musculus deltoideus of 10 animals (group MD) or the gluteus muscle of the other 10 animals (group MG). The average weight of animals was 2726 g (SD = 514) in group MD and 2591 g (SD = 285) in group MG. There were 5 males and 5 females in each group. Because of the naturally aggressive behaviour of rhesus monkeys, the injection was administered after the animal was placed in the observational cage (size 1.5 m × 1.5 m × 2 m) and while it was temporarily immobilized using the retractable rear wall of the cage. After administration of the drug, the animals were observed for behavioural changes, i.e. sedation, ataxia, tactile reaction, loss of aggressiveness. Following parameters were measured: lag time (an interval to the first signs of sedation and ataxia), immobilisation time (interval to lying down) and loss of grasp reflex (interval to loss of clench of a finger of an examiner after touching the palm of an animal). As soon as we were able to remove the monkey from the cage (after loss of aggressiveness), we began measuring basic cardiorespiratory parameters (pulse rate and oxygen saturation of haemoglobin -SpO 2 ) by a pulse oximeter (Nonin 80500 V) that was placed on a finger of the thoracic limb. These measurements were taken after 3 min and 5 min and then every 5 min for 20 min. After this period, the alpha2-adrenoreceptor antagonist, atipamezole, was administered at a dose of 250 µg·kg -1 to the deltoid muscle and again behavioural changes were observed.
Statistical analysis Cardiorespiratory parameters were evaluated using two-way repeated measures ANOVA with post hoc StudentNewman-Keuls t-test. All statistical tests used a two-tailed criterion, with a significance level of P < 0.05. For the ANOVA tests, F ratios (variance of the group means/mean of the within-group variance) with the corresponding degrees of freedom were presented.
Results
The main results are presented in Table 1 . In group MG, no data for cardiorespiratory parameters could be obtained in the 3 rd min after administration of the drug because of the preserved consciousness and aggressiveness of the animals. There were highly significant differences (P < 0.001) between groups MG and MD in the onset of effect and immobilisation time. In the MG group, the grasp reflex was still present at the beginning of immobilisation and slowly wore off in 15-45 s. The same was valid for the muscle tone. The heart rate and SpO 2 values during immobilisation and recovery did not differ between groups. Animals of both groups recovered on average 3-6 min after atipamezole administration.
Discussion
Studies examining the differences between various sites of injections are rare and sometimes conflicting (Tuttle 1977; Grabinski et al. 1983; Clutton et al. 1998 ). Our results demonstrate that the site of intramuscular administration is important for the onset of the anaesthetic effect. These finding are supported by studies examining pharmacokinetics of some drugs administered to various sites. Peak plasma concentration of 0.34 ± 0.1 µg·l -1 of the drug was achieved after 1.6-1.7 h when 1.5 µg·kg -1 dexmedetomidine was injected to the gluteus muscle (Scheinin et al. 1992) . When 2.0 µg·kg -1 dexmedetomidine was administered to the deltoid muscle, the peak plasma concentration of 0.81 ± 0.27 ng·ml -1 of the drug was achieved after 12 (2-60) min (Dyck et al. 1993) . Evans et al. (1975) measured the blood flow in various muscles by Xe 133 . Blood perfusion of the deltoid muscle (11.6 ± 0.5 ml/100 g/min) was significantly higher (P < 0.05) than blood perfusion of the gluteus muscle (9.6 ± 0.5 ml/l00 g/min). Blood flow in the same muscle volume is approximately 20% higher in the deltoid muscle and it means higher systemic absorption and more rapid increase of plasmatic concentration of the drug. Virkkila et al. (1993) studied the pharmacokinetics of 12.5 µg·kg -1 alfentanil administered as premedication either to the deltoid or gluteus maximus muscle 15 min before peribulbar block in ophthalmic surgery in humans. They found significantly increased plasma concentration after the deltoid administration and only patients with the deltoid administration had reduced pain (measured by visual analogue scale) caused by peribulbar administration of local anaesthetics. Grabinski et al. (1983) discovered that plasma concentration of methadone was 2.5 higher after the deltoid administration than after the gluteal administration. Kentala et al. (1998) studied the pharmacokinetics of a combination 6 µg·kg -1 scopolamine with morphine 200 µg·kg -1 administered either to the deltoid or the gluteal muscle. After injection to the deltoid muscle, the peak plasma concentration of scopolamine 2.2 ng·l -1 was achieved after 17 min versus 1.6 µg·kg -1 and 19 min when scopolamine was administered to the gluteus muscle. Even more prominent were differences in morphine. The appropriate plasmatic concentrations were (deltoid vs. gluteus muscle) 71 ng·l -1 versus 49 ng·l -1 . Maximal sedation was achieved after 60 min in the deltoid group compared with 120-160 min in the gluteal group. The authors concluded that the pharmacokinetics and clinical effect of the scopolamine-morphine combination are more predictable and reliable after injection to the deltoid muscle. Similar situation was published in studies concerning muscle relaxant drugs. Kuntze (1967) demonstrated that the effect of suxamethonium is more rapid after injection to the thoracic limb than to the pelvic limb. He demonstrated in felines, bears and ruminants that after administration of suxamethonium to the tail, the onset of muscle relaxation was significantly delayed and higher doses had to be used.
All studies mentioned above indicated that administration of drugs to the deltoid muscle resulted in a more rapid onset and increased effect of the drug. These conclusions are in agreement with our results. After injection of the combination medetomidine-ketamine to the deltoid muscle, a rapid onset of immobilisation, rapid cessation of the grasp reflex and complete muscle relaxation could be observed. On the other hand, after injection to the gluteus maximus muscle, the onset of immobilisation, loss of the grasp reflex and onset of muscle relaxation were delayed. We can speculate on the exact reason but based on the study of Evans et al. (1975) it is probably due to better blood supply to thoracic limbs.
We are aware that our results were obtained in fasting animals and different times could be obtained in non-fasting animals. We are not able to reproduce our study on non-fasting animals for safety reasons (risk of aspiration of the gastric content), but we can speculate that the differences between two different sites of intramuscular administration will be preserved, although absolute times could be probably prolonged. The results of our study can be applied to humans, too. In the Czech Republic, intramuscular premedication is still commonly applied to the gluteal muscle. Absorption from this area is slow and unpredictable in some drugs such as diazepam (Tuttle 1977) . In adult humans, the effect can be even more modified by a large variety in gluteal fat thickness causing improper deposition of the intended intramuscular injections in the gluteal muscle in some individuals. Burbridge (2007) demonstrated that in a significant number of patients, the medications may be injected subcutaneously and not into the gluteal musculature, possibly altering the pharmacokinetics of the administered medication. The fat tissue is less thick over the deltoid muscle.
We can conclude that the injection of drugs to the deltoid muscle may be more convenient in all cases when a rapid and more prominent effect is desirable as in premedication before surgery or in emergency medicine.
